Republic Healthcare Limited (HKG:8357)
0.1020
+0.0010 (0.99%)
Jun 1, 2026, 1:41 PM HKT
Republic Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 7.96 | 8.66 | 10 | 9.04 | 13.37 |
Other Revenue | 0.18 | 0.57 | 0.28 | 0.4 | 0.61 |
| 8.14 | 9.23 | 10.28 | 9.44 | 13.97 | |
Revenue Growth (YoY) | -11.80% | -10.24% | 8.91% | -32.45% | 0.61% |
Cost of Revenue | 7.39 | 6.97 | 7.58 | 7.55 | 10.43 |
Gross Profit | 0.75 | 2.26 | 2.7 | 1.89 | 3.54 |
Selling, General & Admin | 0.36 | 0.48 | 0.81 | 0.63 | 1.61 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0 | - | - |
Other Operating Expenses | 2.49 | 1.38 | 1.73 | 1.19 | 1.34 |
Operating Expenses | 3.82 | 2.64 | 3.36 | 2.83 | 4.81 |
Operating Income | -3.07 | -0.39 | -0.66 | -0.94 | -1.27 |
Interest Expense | -0.1 | -0.05 | -0.05 | -0.06 | -0.12 |
Interest & Investment Income | 0.21 | 0.21 | 0.26 | 0.03 | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | - | 0.03 |
Other Non Operating Income (Expenses) | - | 0.12 | -0.1 | -0.43 | - |
EBT Excluding Unusual Items | -2.97 | -0.11 | -0.56 | -1.39 | -1.35 |
Impairment of Goodwill | - | - | -0.28 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | - |
Asset Writedown | -0.07 | -0.08 | - | -0.08 | -0 |
Other Unusual Items | 0 | 0.01 | 0.01 | 0 | 0.33 |
Pretax Income | -3.03 | -0.18 | -0.83 | -1.46 | -1.02 |
Income Tax Expense | -0.03 | -0.01 | 0.03 | 0.03 | -0.02 |
Earnings From Continuing Operations | -3.01 | -0.18 | -0.86 | -1.48 | -1 |
Net Income | -3.01 | -0.18 | -0.86 | -1.48 | -1 |
Net Income to Common | -3.01 | -0.18 | -0.86 | -1.48 | -1 |
Shares Outstanding (Basic) | 624 | 624 | 624 | 624 | 551 |
Shares Outstanding (Diluted) | 624 | 624 | 624 | 624 | 551 |
Shares Change (YoY) | - | - | - | 13.30% | 5.92% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Free Cash Flow | -3.34 | 0.05 | 0.82 | -1.16 | -1.13 |
Free Cash Flow Per Share | -0.01 | - | 0.00 | -0.00 | -0.00 |
Gross Margin | 9.26% | 24.45% | 26.24% | 20.02% | 25.36% |
Operating Margin | -37.70% | -4.19% | -6.42% | -9.95% | -9.07% |
Profit Margin | -36.94% | -1.93% | -8.32% | -15.73% | -7.14% |
Free Cash Flow Margin | -41.08% | 0.56% | 7.95% | -12.26% | -8.10% |
EBITDA | -2.94 | -0.19 | -0.45 | -0.65 | -0.63 |
EBITDA Margin | -36.09% | -2.05% | -4.34% | -6.90% | -4.52% |
D&A For EBITDA | 0.13 | 0.2 | 0.21 | 0.29 | 0.64 |
EBIT | -3.07 | -0.39 | -0.66 | -0.94 | -1.27 |
EBIT Margin | -37.70% | -4.19% | -6.42% | -9.95% | -9.07% |